多个证券诉讼指控生物技术公司误导投资者,造成股票损失。 Multiple securities lawsuits accuse biotech firms of misleading investors, causing stock losses.

对生物技术公司Biohaven有限公司、Savara公司、Capricor治疗公司和LifeMD公司提起了若干集体证券诉讼。 Several class-action securities lawsuits have been filed against biotech companies Biohaven Ltd., Savara Inc., Capricor Therapeutics, Inc., and LifeMD, Inc. 诉讼指控这些公司作出虚假陈述或隐瞒有关其药物发展和金融前景的信息,从而导致大量库存损失。 The lawsuits accuse the companies of making false statements or concealing information about their drug development and financial prospects, leading to significant stock losses. 在特定时期内遭受损失的投资者被邀请通过Levi & Korsinsky LLP和Faruqi & Faruqi等法律公司参加诉讼,这些公司历来为受害股东争取赔偿。 Investors who suffered losses during specified periods are invited to join the lawsuits via legal firms like Levi & Korsinsky LLP and Faruqi & Faruqi, LLP, which have a history of securing compensation for aggrieved shareholders.